AGORACOM Small-cap Investor Relations Blog

Kontrol Energy Corp. ( CSE: KNR ) ( OTCQB: KNRLF ) ( FSE: 1K8 ) will be hosting a webinar presentation  for investors, analysts and media for its Covid-19 detection technology (“BioCloud analyzer” or “BioCloud”). The purpose of the presentation is to provide an operating demonstration and take questions from the audience.

“Following the filing of our patent applications we are excited to demonstrate how the BioCloud technology operates and share that with the public,” says Paul Ghezzi , CEO Kontrol. “We will be providing a demonstration of BioCloud and access to the inner workings of the technology.”

Title:  Kontrol to host BioCloud technology presentation for investors, analysts and media

Event date:  Thursday, Dec. 17, 2020, at 4:30 p.m. Eastern Time

Presentation type:  audio with presenter controlled slides and teleconference

Webcast event link:  https://www.webcaster4.com/Webcast/Page/2402/39134

Participant numbers  

Toll-free:  877-407-0782

International:  201-689-8567

–Safe Space Technology™–

TORONTO , Dec. 9, 2020 – Kontrol Energy Corp. ( CSE: KNR ) ( OTCQB: KNRLF ) ( FSE: 1K8 ) (” Kontrol ” or ” Company “) is pleased to announce that it will be hosting a webinar presentation  for investors, analysts and media for its Covid-19 detection technology (“BioCloud analyzer” or “BioCloud”). The purpose of the presentation is to provide an operating demonstration and take questions from the audience.

“Following the filing of our patent applications we are excited to demonstrate how the BioCloud technology operates and share that with the public,” says Paul Ghezzi , CEO Kontrol. “We will be providing a demonstration of BioCloud and access to the inner workings of the technology.”

As previously announced on November 30, 2020 , Kontrol has filed the following four patent applications for its BioCloud technology and the Company is pleased to provide the patent references:

UNITED STATES : Application No. 17/105,793
SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS

UNITED STATES : Application No. 17/105,813
SYSTEM AND METHOD FOR OPTICAL DETECTION OF PATHOGENS

UNITED STATES : Application No. 17/105,804
COLLECTION CHAMBER FOR AN AIR SAMPLING SYSTEM

CANADA
SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS

About Kontrol BioCloud TM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.

Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.

About Kontrol Energy

Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date.  Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.  

SOURCE Kontrol Energy Corp.

Initial sales, distribution agreements, filed patents and Government funding move BioCloud into the market

• Set to ship its COVID-19 technology (“Kontrol BioCloud” or “BioCloud”) BioCloud, to customers and distributors around the world.
• BioCloud is a real-time analyzer designed to detect airborne viruses, including SARS-COV-2, by continuously sampling air quality and triggering a silent, cloud-based alert to facility managers.

TORONTO , Dec. 8, 2020 – Kontrol Energy Corporation (“Kontrol” or the “Company”), a Canadian public Company (CSE: KNR) (OTCQB: KNRLF), is set to ship its COVID-19 technology (“Kontrol BioCloud” or “BioCloud”) BioCloud, to customers and distributors around the world. BioCloud is a real-time analyzer designed to detect airborne viruses, including SARS-COV-2, by continuously sampling air quality and triggering a silent, cloud-based alert to facility managers.

Initial contracts include sales with Kontrol customers and non-exclusive distribution and an exclusive distribution agreement for North America , Australia and New Zealand with United Safety and Survivability Corp.

Patents Filed
On November 30th, 2020 the Company announced the filing of 4 patents for the BioCloud technology with 3 patents filed in the USA and 1 patent in Canada .

“The focus of our BioCloud technology is to help create safer spaces globally as we collectively continue to face the challenge of the COVID-19 pandemic,” says Paul Ghezzi , CEO Kontrol. “Initial deliveries are set to arrive to Kontrol customers and distributors in January 2021 . Our team has been working around the clock to launch BioCloud into the global market.”

Manufacturing
With COVID-19 cases spiking globally and with increases anticipated into the winter season, BioCloud distribution plans are in high gear.

“We have the required local manufacturing capability to meet anticipated production volumes,” says Gary Saunders , VP of Kontrol.  “We are pleased that the majority of our supply chain is Canadian.”

Kontrol has engaged OES Inc. a local design and contract manufacturer in London, Ontario to produce the BioCloud units.  OES Inc. has a long and established history of assisting with the design and manufacturing of complex technology.

“Having BioCloud developed and now being produced in Ontario, Canada is very important to us,” continues Paul Ghezzi . “Our plans to have the initial production and supply chain sourced in Canada means that we are creating jobs while helping to solve the global pandemic that is COVID-19.”

“OES has the ability and capacity to ramp up to meet the required BioCloud manufacturing requirements and we can also scale with BioCloud as required,” says Jeff Stewart , President OES Inc. “We are committed to supporting local jobs, growth and Ontario exports.”

Kontrol receives additional federal funding
On December 3rd, 2020 the Company announced that it had received advisory services and additional $500,000 in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) .

“This is another important accomplishment and milestone for Kontrol and represents the continuing advancement of the BioCloud technology,” continues Paul Ghezzi . “We are grateful for and proud of this support from our federal government.”

Kontrol’s distribution agreement with United Safety and Survivability Corp
Under the terms of the agreement, the exclusivity applies to the industries defined as buses, rail and locomotive, subways, ambulances, fire trucks, first responder and military vehicles, with applicable associated facilities in the geography of North America , Australia , and New Zealand . The exclusivity period is 12 months with a six month mutual renewal option and is based on 5,000 units of BioCloud per annum, on a best efforts basis, to retain exclusivity. Pricing will not be disclosed for industry competitive purposes.

Joseph Mirabile , CEO of United Safety stated, “United Safety and Survivability Corporation is committed to delivering the most innovative and reliable solutions that our customers trust to protect life and property. We are very excited to be sharing the Kontrol BioCloud technology with all of our customers. We see interest and demand for this innovative technology, which can help create safer spaces and help our customers solve many of the challenges they are facing in relation to the impact COVID-19 has on their business.”

Ongoing Service
The patented and proprietary detection chamber is at the heart of BioCloud. The detection chamber is a consumable that needs to be replaced when it comes into contact with the SARS- CoV-2 virus.  Kontrol is launching a new service to assist customers with the disposal and recycling of BioCloud’s propriety detection chamber.

The service allows for customers to return and recycle the detection chamber and receive a discount on future purchases of consumable detection chambers.

“This new service is a win-win as Kontrol is able to recycle various materials and customers are able to receive a discount on future purchases of the BioCloud consumables,” continues Gary Saunders .

Purchase
The Company estimates a $12,000 USD per unit sale price for BioCloud based on current supply chain components. However, the Company offers volume discounts for aggregate purchases and further, the Company will offer a financing plan should customers require it.

About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.

Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).  Safe Space Technology is a Kontrol Trademark.

About Kontrol Energy
Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

Visit https://www.kontrolbiocloud.com/ for future updates, BioCloud demonstrations and to place orders.

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE Kontrol Energy Corporation